BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15667216)

  • 21. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity.
    Tsiang M; Lentz SR; Sadler JE
    J Biol Chem; 1992 Mar; 267(9):6164-70. PubMed ID: 1313430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombin inhibition by cyclic peptides from thrombomodulin.
    Lougheed JC; Bowman CL; Meininger DP; Komives EA
    Protein Sci; 1995 Apr; 4(4):773-80. PubMed ID: 7613475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function.
    Clarke JH; Light DR; Blasko E; Parkinson JF; Nagashima M; McLean K; Vilander L; Andrews WH; Morser J; Glaser CB
    J Biol Chem; 1993 Mar; 268(9):6309-15. PubMed ID: 8384206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Energetics of thrombin-thrombomodulin interaction.
    Vindigni A; White CE; Komives EA; Di Cera E
    Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further localization of binding sites for thrombin and protein C in human thrombomodulin.
    Hayashi T; Zushi M; Yamamoto S; Suzuki K
    J Biol Chem; 1990 Nov; 265(33):20156-9. PubMed ID: 2173698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombomodulin structure and function.
    Sadler JE
    Thromb Haemost; 1997 Jul; 78(1):392-5. PubMed ID: 9198185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.
    Kokame K; Zheng X; Sadler JE
    J Biol Chem; 1998 May; 273(20):12135-9. PubMed ID: 9575159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity.
    Nagashima M; Lundh E; Leonard JC; Morser J; Parkinson JF
    J Biol Chem; 1993 Feb; 268(4):2888-92. PubMed ID: 8381415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of monoclonal antibodies to thrombomodulin.
    Tsuneyoshi N; Fukudome K; Higuchi K; Kimoto M
    Hybridoma (Larchmt); 2005 Aug; 24(4):189-96. PubMed ID: 16120024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site.
    Kurosawa S; Stearns DJ; Jackson KW; Esmon CT
    J Biol Chem; 1988 May; 263(13):5993-6. PubMed ID: 2834358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities.
    Gasper PM; Fuglestad B; Komives EA; Markwick PR; McCammon JA
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21216-22. PubMed ID: 23197839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.
    Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W
    Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles played by the D2 and D3 domains of recombinant human thrombomodulin in its function.
    Honda G; Masaki C; Zushi M; Tsuruta K; Sata M
    J Biochem; 1995 Nov; 118(5):1030-6. PubMed ID: 8749323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells.
    Hamada H; Ishii H; Sakyo K; Horie S; Nishiki K; Kazama M
    Blood; 1995 Jul; 86(1):225-33. PubMed ID: 7795228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of thrombomodulin activation of slow thrombin.
    Adams TE; Li W; Huntington JA
    J Thromb Haemost; 2009 Oct; 7(10):1688-95. PubMed ID: 19656282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies for human thrombomodulin which recognize binding sites for thrombin and protein C.
    Hayashi T; Suzuki K
    J Biochem; 1990 Nov; 108(5):874-8. PubMed ID: 1964460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fourth epidermal growth factor-like domain of thrombomodulin interacts with the basic exosite of protein C.
    Yang L; Rezaie AR
    J Biol Chem; 2003 Mar; 278(12):10484-90. PubMed ID: 12529320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity.
    Zushi M; Gomi K; Yamamoto S; Maruyama I; Hayashi T; Suzuki K
    J Biol Chem; 1989 Jun; 264(18):10351-3. PubMed ID: 2543666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis.
    Conway EM; Pollefeyt S; Collen D; Steiner-Mosonyi M
    Blood; 1997 Jan; 89(2):652-61. PubMed ID: 9002969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosite 2-Directed Ligands Attenuate Protein C Activation by the Thrombin-Thrombomodulin Complex.
    Chen K; Stafford AR; Wu C; Yeh CH; Kim PY; Fredenburgh JC; Weitz JI
    Biochemistry; 2017 Jun; 56(24):3119-3128. PubMed ID: 28549218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.